Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia

Schizophrenia Research

Volumn 144, Issue 1-3, 2013, Pages 1-8

  Shan, Dan ^a   Lucas, Elizabeth K ^b   Drummond, Jana B ^a   Haroutunian, Vahram ^b   Meador Woodruff, James H ^a,c   McCullumsmith, Robert E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Excitatory amino acid transporter (EAAT); Glutamate; Hippocampus; Schizophrenia; Superior temporal gyrus; Vesicular glutamate transporter (VGLUT)

Indexed keywords

BETA TUBULIN; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; EXCITATORY AMINO ACID TRANSPORTER 4; GLUTAMATE TRANSPORTER; HALOPERIDOL; NEUROLEPTIC AGENT; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2;

AGED; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATION CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; SCHIZOPHRENIA; SUPERIOR TEMPORAL GYRUS; SYNAPSE; TEMPORAL LOBE; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANIMALS; ANTIPSYCHOTIC AGENTS; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; FEMALE; GENE EXPRESSION REGULATION; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; HALOPERIDOL; HIPPOCAMPUS; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; TEMPORAL LOBE; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

EID: 84873523171     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.12.019     Document Type: Article

References (82)

1. Bar-Peled O., Ben-Hur H., Biegon A., Groner Y., Dewhurst S., Furuta A., Rothstein J.D. Distribution of glutamate transporter subtypes during human brain development. J. Neurochem. 1997, 69(6):2571-2580.
2. Bauer D., Gupta D., Harotunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr. Res. 2008, 104(1-3):108-120.
3. Bauer D., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia. Schizophr. Res. 2010, 117(1):92-98.
4. Bellocchio E.E., Reimer R.J., Fremeau R.T., Edwards R.H. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 2000, 289(5481):957-960.
5. Benes F.M., Sorensen I., Bird E.D. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr. Bull. 1991, 17(4):597-608.
6. Bogerts B., Ashtari M., Degreef G., Alvir J.M., Bilder R.M., Lieberman J.A. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res. 1990, 35(1):1-13.
7. Boyer P., Phillips J.L., Rousseau F.L., Ilivitsky S. Hippocampal abnormalities and memory deficits: new evidence of a strong pathophysiological link in schizophrenia. Brain Res. Rev. 2007, 54(1):92-112.
8. Brady A.M., Saul R.D., Wiest M.K. Selective deficits in spatial working memory in the neonatal ventral hippocampal lesion rat model of schizophrenia. Neuropharmacology 2010, 59(7-8):605-611.
9. Bridges R., Lutgen V., Lobner D., Baker D.A. Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol. Rev. 2012, 64(3):780-802.
10. Bruder G., Kayser J., Tenke C., Amador X., Friedman M., Sharif Z., Gorman J. Left temporal lobe dysfunction in schizophrenia: event-related potential and behavioral evidence from phonetic and tonal dichotic listening tasks. Arch. Gen. Psychiatry 1999, 56(3):267-276.
11. Chaudhry F.A., Lehre K.P., van Lookeren Campagne M., Ottersen O.P., Danbolt N.C., Storm-Mathisen J. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 1995, 15(3):711-720.
12. Conradt M., Storck T., Stoffel W. Localization of N-glycosylation sites and functional role of the carbohydrate units of GLAST-1, a cloned rat brain l-glutamate/l-aspartate transporter. Eur. J. Biochem. 1995, 229(3):682-687.
13. Cotter D., Mackay D., Landau S., Kerwin R., Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 2001, 58(6):545-553.
14. Cotter D.R., Pariante C.M., Everall I.P. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res. Bull. 2001, 55(5):585-595.
15. Cotter D., Mackay D., Chana G., Beasley C., Landau S., Everall I.P. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb. Cortex 2002, 12(4):386-394.
16. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65(1):1-105.
17. Daniels R.W., Collins C.A., Gelfand M.V., Dant J., Brooks E.S., Krantz D.E., DiAntonio A. Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J. Neurosci. 2004, 24(46):10466-10474.
18. Daniels R.W., Collins C.A., Chen K., Gelfand M.V., Featherstone D.E., DiAntonio A. A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle. Neuron 2006, 49(1):11-16.
19. De Souza I.E., McBean G.J., Meredith G.E. Chronic haloperidol treatment impairs glutamate transport in the rat striatum. Eur. J. Pharmacol. 1999, 382(2):139-142.
20. Eastwood S.L., Harrison P.J. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol. Psychiatry 2000, 5(4):425-432.
21. Eastwood S.L., Harrison P.J. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr. Res. 2005, 73(2-3):159-172.
22. Egan M.F., Straub R.E., Goldberg T.E., Yakub I., Callicott J.H., Hariri A.R., Mattay V.S., Bertolino A., Hyde T.M., Shannon-Weickert C., Akil M., Crook J., Vakkalanka R.K., Balkissoon R., Gibbs R.A., Kleinman J.E., Weinberger D.R. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(34):12604-12609.
23. Falkai P., Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur. Arch. Psychiatry Neurol. Sci. 1986, 236(3):154-161.
24. Fatemi S.H., Earle J.A., Stary J.M., Lee S., Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 2001, 12(15):3257-3262.
25. Fujimoto T., Okumura E., Takeuchi K., Kodabashi A., Tanaka H., Otsubo T., Nakamura K., Sekine M., Kamiya S., Higashi Y., Tsuji M., Shimooki S., Tamura T. Changes in event-related desynchronization and synchronization during the auditory oddball task in schizophrenia patients. Open Neuroimaging J. 2012, 6:26-36.
26. Furuta A., Martin L.J., Lin C.L., Dykes-Hoberg M., Rothstein J.D. Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4. Neuroscience 1997, 81(4):1031-1042.
27. Furuta A., Rothstein J.D., Martin L.J. Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J. Neurosci. 1997, 17(21):8363-8375.
28. Harrison P.J., Law A.J., Eastwood S.L. Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann. N. Y. Acad. Sci. 2003, 1003:94-101.
29. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 2001, 11(5):520-528.
30. Heckers S., Konradi C. Hippocampal neurons in schizophrenia. J. Neural Transm. 2002, 109(5-6):891-905.
31. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 1994, 17:31-108.
32. Horiuchi Y., Iida S., Koga M., Ishiguro H., Iijima Y., Inada T., Watanabe Y., Someya T., Ujike H., Iwata N., Ozaki N., Kunugi H., Tochigi M., Itokawa M., Arai M., Niizato K., Iritani S., Kakita A., Takahashi H., Nawa H., Arinami T. Association of SNPs linked to increased expression of SLC1A1 with schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2012, 159B(1):30-37.
33. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol. Psychiatry 2000, 5(2):142-149.
34. Karlsson R.M., Tanaka K., Heilig M., Holmes A. Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. Biol. Psychiatry 2008, 64(9):810-814.
35. Karlsson R.M., Tanaka K., Saksida L.M., Bussey T.J., Heilig M., Holmes A. Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsychopharmacology 2009, 34(6):1578-1589.
36. Kugler P., Schmitt A. Glutamate transporter EAAC1 is expressed in neurons and glial cells in the rat nervous system. Glia 1999, 27(2):129-142.
37. Lauriat T.L., Dracheva S., Chin B., Schmeidler J., McInnes L.A., Haroutunian V. Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience 2006, 137(3):843-851.
38. Le Corre S., Harper C.G., Lopez P., Ward P., Catts S. Increased levels of expression of an NMDARI splice variant in the superior temporal gyrus in schizophrenia. Neuroreport 2000, 11(5):983-986.
39. Lehre K.P., Levy L.M., Ottersen O.P., Storm-Mathisen J., Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 1995, 15(3 Pt 1):1835-1853.
40. Liguz-Lecznar M., Skangiel-Kramska J. Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system. Acta Neurobiol. Exp. (Wars) 2007, 67(3):207-218.
41. Lipska B.K. Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J. Psychiatry Neurosci. 2004, 29(4):282-286.
42. Maragakis N.J., Rothstein J.D. Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis. 2004, 15(3):461-473.
43. Masson J., Sagne C., Hamon M., El Mestikawy S. Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 1999, 51(3):439-464.
44. Matute C., Melone M., Vallejo-Illarramendi A., Conti F. Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics. Glia 2005, 49(3):451-455.
45. McCullumsmith R.E., Meador-Woodruff J.H. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 2002, 26(3):368-375.
46. Melone M., Vitellaro-Zuccarello L., Vallejo-Illarramendi A., Perez-Samartin A., Matute C., Cozzi A., Pellegrini-Giampietro D.E., Rothstein J.D., Conti F. The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine. Mol. Psychiatry 2001, 6(4):380-386.
47. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998, 281(5381):1349-1352.
48. Nelson M.D., Saykin A.J., Flashman L.A., Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch. Gen. Psychiatry 1998, 55(5):433-440.
49. Nudmamud-Thanoi S., Piyabhan P., Harte M.K., Cahir M., Reynolds G.P. Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. J. Neural Transm. Suppl. 2007, (72):281-285.
50. Ohnuma T., Augood S.J., Arai H., McKenna P.J., Emson P.C. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res. Mol. Brain Res. 1998, 56(1-2):207-217.
51. Ohnuma T., Tessler S., Arai H., Faull R.L., McKenna P.J., Emson P.C. Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. Brain Res. Mol. Brain Res. 2000, 85(1-2):24-31.
52. Oni-Orisan A., Kristiansen L.V., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol. Psychiatry 2008, 63(8):766-775.
53. Peghini P., Janzen J., Stoffel W. Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J. 1997, 16(13):3822-3832.
54. Pothos E.N., Larsen K.E., Krantz D.E., Liu Y., Haycock J.W., Setlik W., Gershon M.D., Edwards R.H., Sulzer D. Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J. Neurosci. 2000, 20(19):7297-7306.
55. Rajarethinam R.P., DeQuardo J.R., Nalepa R., Tandon R. Superior temporal gyrus in schizophrenia: a volumetric magnetic resonance imaging study. Schizophr. Res. 2000, 41(2):303-312.
56. Rajarethinam R., Sahni S., Rosenberg D.R., Keshavan M.S. Reduced superior temporal gyrus volume in young offspring of patients with schizophrenia. Am. J. Psychiatry 2004, 161(6):1121-1124.
57. Rajkowska G., Miguel-Hidalgo J.J., Makkos Z., Meltzer H., Overholser J., Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 2002, 57(2-3):127-138.
58. Rao J.S., Kellom M., Reese E.A., Rapoport S.I., Kim H.W. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J. Affect. Disord. 2012, 136(1-2):63-71.
59. Raunser S., Haase W., Bostina M., Parcej D.N., Kuhlbrandt W. High-yield expression, reconstitution and structure of the recombinant, fully functional glutamate transporter GLT-1 from Rattus norvegicus. J. Mol. Biol. 2005, 351(3):598-613.
60. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 1994, 13(3):713-725.
61. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16(3):675-686.
62. Schmitt A., Asan E., Puschel B., Kugler P. Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: nonradioactive in situ hybridization and comparative immunocytochemistry. J. Neurosci. 1997, 17(1):1-10.
63. Schneider J.S., Wade T., Lidsky T.I. Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum. Neuroreport 1998, 9(1):133-136.
64. Schroeder H., Grecksch G., Becker A., Bogerts B., Hoellt V. Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion. Psychopharmacology (Berl.) 1999, 145(1):61-66.
65. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 2007, 51(6-7):333-355.
66. Shigeri Y., Seal R.P., Shimamoto K. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Brain Res. Rev. 2004, 45(3):250-265.
67. Smith R.E., Haroutunian V., Davis K.L., Meador-Woodruff J.H. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am. J. Psychiatry 2001, 158(9):1393-1399.
68. Sokolov B.P., Tcherepanov A.A., Haroutunian V., Davis K.L. Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients. Biol. Psychiatry 2000, 48(3):184-196.
69. Stark A.K., Uylings H.B., Sanz-Arigita E., Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am. J. Psychiatry 2004, 161(5):882-888.
70. Steen R.G., Mull C., McClure R., Hamer R.M., Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 2006, 188:510-518.
71. Steffek A.E., McCullumsmith R.E., Haroutunian V., Meador-Woodruff J.H. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr. Res. 2008, 103(1-3):71-82.
72. Takamori S., Rhee J.S., Rosenmund C., Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 2000, 407(6801):189-194.
73. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276(5319):1699-1702.
74. Trotti D., Aoki M., Pasinelli P., Berger U.V., Danbolt N.C., Brown R.H., Hediger M.A. Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J. Biol. Chem. 2001, 276(1):576-582.
75. Tseng K.Y., Chambers R.A., Lipska B.K. The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behav. Brain Res. 2009, 204(2):295-305.
76. Tzingounis A.V., Wadiche J.I. Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Nat. Rev. Neurosci. 2007, 8(12):935-947.
77. Uezato A., Meador-Woodruff J.H., McCullumsmith R.E. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Bipolar Disord. 2009, 11(7):711-725.
78. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 2004, 67(2-3):269-275.
79. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320(5875):539-543.
80. Watanabe, et al. GPS1, interacting protein with GLT-1. Program No 37216 2003 SFN Abstract 2003.
81. Wilson N.R., Kang J., Hueske E.V., Leung T., Varoqui H., Murnick J.G., Erickson J.D., Liu G. Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J. Neurosci. 2005, 25(26):6221-6234.
82. Young C.E., Arima K., Xie J., Hu L., Beach T.G., Falkai P., Honer W.G. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb. Cortex 1998, 8(3):261-268.